Cancer is fundamentally a genetic disease caused by alterations in the DNA. These alterations can lead to uncontrolled cell growth and tumor formation. By focusing on the exome, researchers can identify mutations that drive cancer development and progression. Since exome sequencing targets only the protein-coding regions, it provides a cost-effective and comprehensive method to pinpoint these critical mutations, enabling better understanding and potential treatment options.
